CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Well Known Stock Indices Worldwide gathers popular indices from different continents. Use this global snapshot to gauge market health.
21,921 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A decade can dramatically change a portfolio. This article explores how you'd invested $10,000 Walmart ten years ago ...
Salesforce unveiled a $50 billion buyback and a new AI metric, but traders remain wary that AI disruption could erode...
NVIDIA’s shares hover near $198 as investors weigh whether the AI leader’s growth justifies a premium. The stock now ...
In 2026, two very different gaming plays compete for attention: Roblox as a high-growth platform and GameStop as a tu...
AAI disruption is reshaping markets, and Nvidia sits at the center. This piece breaks down how billionaires instituti...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
NVIDIA shattered expectations with a historic earnings beat, but its stock moved lower as traders reassessed forward ...
Looking ahead at geron (gern) 2026 earnings, this guide breaks down the catalysts, cash runway, and risks shaping the...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
Oracle posted a strong quarter with a beat and raise, but the stock traded lower after earnings. This piece breaks do...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...